Form 4 for AGL agilon health, inc.
Accepted 2023-04-18 00:00:00 ET · period of report 2023-04-14 · accession 0001209191-23-024677 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-18 | 2023-04-14 | AGL | Schwaneke Jeffrey A. | Dir | A - Grant | $0.00 | +5,622 | 9,631 | +140% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-14 | A | A | 5,622 | $0.00 | 9,631 | D | — | — | (F1) Restricted stock units that vest in full on April 14, 2024, subject to continued service as a director. (F2) Includes restricted stock units. |